Daito Pharmaceutical Co.,Ltd. (TYO:4577)

Japan · Delayed Price · Currency is JPY

1,309.00

+3.00 (0.23%)

Oct 2, 2026, 3:30 PM JST

Market Cap	36.99B +4.2%
Revenue (ttm)	50.65B +0.0%
Net Income	3.16B +65.7%
EPS	107.47 +71.3%
Shares Out	28.26M
PE Ratio	12.18
Forward PE	14.76
Dividend	45.00 (3.44%)
Ex-Dividend Date	Nov 27, 2026

Volume	87,900
Open	1,300.00
Previous Close	1,306.00
Day's Range	1,296.00 - 1,324.00
52-Week Range	1,120.00 - 1,521.00
Beta	0.20
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 14, 2026

About Daito Pharmaceutical

Daito Pharmaceutical Co.,Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs. The company is also involved in the wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries. The company was formerly known as Daito Corporation and changed its nam... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1942

Employees 1,085

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4577

Full Company Profile

Financial Performance

In fiscal year 2026, Daito Pharmaceutical's revenue was 50.65 billion, an increase of 0.01% compared to the previous year's 50.64 billion. Earnings were 3.16 billion, an increase of 65.67%.

Financial Statements